
Test once. Know.
Delve Bio is a clinical diagnostics company on a mission to revolutionize infectious disease testing by bringing metagenomic next-generation sequencing (mNGS) testing out of the research lab and into the clinic. Founded by leading experts in infectious disease, Delve Bio's platform enables clinicians to test once and know — ending the era of sequential, time-consuming guess-and-test diagnostics. The company's Delve Detect product connects clinicians with medical experts for clinical consults and result interpretation, leveraging mNGS to identify pathogens across a broad range of infectious diseases in a single test.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create a free account to see which investors have funded this company.
Create Free Account